NEA 18 VENTURE GROWTH EQUITY, L.P. -- ZENAS BIOPHARMA, INC. 13G

Company

Zenas BioPharma, Inc.

Filed

September 25, 2024

Accession Number

0001072613-24-000733

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →